Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158665 · ClinicalTrials.gov registry record · NA
A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years of Age
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 280
- Enrollment target
NCT00158665 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 280 participants.
The verdict
NCT00158665, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
Study Summary
The purpose of the study was to find out if children 5 through 8 years of age who are getting influenza vaccine for the first time should get one or two doses.
Interventions
- BIOLOGICAL 2 0.5 ml doses of '04-05 Trivalent Influenza Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2004-08 |
| Est. Completion | 2004-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00158665
The ClinicalTrials.gov registry entry for NCT00158665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 2 0.5 ml doses of '04-05 Trivalent Influenza Vaccine is the first listed.
NCT00158665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00158665 about?
NCT00158665 is a clinical study titled "A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years of Age". The purpose of the study was to find out if children 5 through 8 years of age who are getting influenza vaccine for the first time should get one or two doses.
What is the current status of trial NCT00158665?
This trial is currently completed. It is a NA study. The enrollment target is 280 participants. The study started on 2004-08. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00158665?
The interventions under investigation include: 2 0.5 ml doses of '04-05 Trivalent Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00158665?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.